Rotavirus Vaccines Completed Phase 3 Trials for Rotavirus vaccine (DB10276)

Also known as: Rotavirus Vaccine

IndicationStatusPhase
DBCOND0033911 (Rotavirus Vaccines)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00480324Efficacy, Safety, Reactogenicity & Immunogenicity of the Rotarix Vaccine in Japanese InfantsPrevention
NCT03207750This Study Will Evaluate the Immunogenicity, Reactogenicity and Safety of the Routine Infant Vaccines Pediarix®, Hiberix® and Prevenar 13® When Co-administered With GlaxoSmithKline (GSK) Biologicals' Liquid Human Rotavirus Vaccine (HRV) as Compared to GSK's Licensed Lyophilized VaccinePrevention
NCT02914184Evaluation of Immunogenicity and Safety of Two Formulations of GSK Biologicals' Human Rotavirus (HRV) Vaccine (444563), in Healthy Infants Starting at Age 6-12 WeeksPrevention
NCT00241644Vaccine Efficacy Against Rotavirus Diarrhea; Vaccine Given With Routine Childhood Vaccinations in Healthy African InfantsPrevention
NCT00757770Assessment of Clinical Consistency of Three Production Lots of GSK Biologicals' HRV VaccinePrevention
NCT02193061Randomized, Controlled Single-blind Clinical Study to Assess Vaccine Interchangeability Between RV5 and RV1 Using Seven Combined Anti-rotavirus Prevention ProgramsPrevention